A carregar...
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
LE Dockery, CC Gunderson, KN Moore Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA Abstract: Rucaparib camsylate (CO-338, AG-014699, PF-01367338) is a potent PARP-1, PARP-2, an...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017-06-01
|
| Colecção: | OncoTargets and Therapy |
| Assuntos: | |
| Acesso em linha: | https://www.dovepress.com/rucaparib-the-past-present-and-future-of-a-newly-approved-parp-inhibit-peer-reviewed-article-OTT |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|